Patients have a naïve optimism about medical care. A new study in JAMA found that patients have an unrealistic expectation of the benefits and harms of common medical treatments, tests, and screens.
Patients have a naïve optimism about medical care. A new study in JAMA found that patients have an unrealistic expectation of the benefits and harms of common medical treatments, tests, and screens.
These expectations may be contributing the increased interventions and healthcare costs, according to authors Tammy C. Hoffmann, PhD, from the University of Queensland, Brisbane, Australia, and Bond University, Queensland, Australia; and Chris Del Mar, MD, FRACGP, from Bond University.
Among the 15,343 papers they screen, 35 involving 27,323 patients were eligible. Most screening studies were about cancer screening. Various treatments studied included surgery, medications, and other things like cardiopulmonary resuscitation.
Overall, most people overestimated the benefits of an intervention and underestimated the harms, the authors wrote on the University of Queensland website
“Across most studies, the proportion of people who correctly estimated intervention benefits and harms was generally low,” they wrote. “In other words, people appear to have set a halo around medical care, expecting it to deliver better outcomes than is reality.”
There was only one study (out of the 35 reviewed) where the majority of participants actually underestimated the benefit, and another study where the majority overestimated the harm.
Some of the likely factors for this phenomenon include the assumption that more healthcare is better and clinicians wanting to convey hope and encouragement. The authors believe overly optimistic expectations have contributed to the increasing use of health services.
The researchers named a number of groups responsible to counteract the unrealistic expectations of patients: researchers, journalists, health services and the pharmaceutical industry, and clinicians.
“In the process of negotiating the best clinical option, clinicians should elicit the patient’s expectations and preconceptions about what they are expecting from the intervention, discuss any misperceptions, and provide accurate information about the benefits and harms of each management option,” Drs Hoffman and Del Mar concluded in their paper.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Insurance Coverage Limits JAKi Therapy Access for Patients With AA, Especially Non-White Populations
April 25th 2024A survey study showed major barriers to Janus kinase inhibitor (JAKi) therapy for patients with alopecia areata, especially for non-White patients who face higher rates of being uninsured and struggle more to afford the treatment.
Read More